SciSparc Develops Innovative Solutions for Central Nervous System Disorders

Jul. 6, 2022 | RedChip Companies


SciSparc, a specialty pharmaceutical company, is working on drug clinical trials with applications for Tourette Syndrome, Obstructive Sleep Apnea, Alzheimer’s Disease and Agitation, Autism Spectrum Disorder, and two in pre-clinical studies for Status Epilepticus, and Chronic Pain. They just released news on their newest product that will be the first of its kind to treat Paine addiction which is a major problem in the U.S. with over 100,000 drug overdoses in 2021 alone. Learn more about the company at scisparc.com.



"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market